Teprotumumab reduces the proliferation and viability of pterygium fibroblasts.
- DOI
- 10.1016/j.exer.2025.110589
- Published
- 2025-08-20
- Container
- Exp Eye Res
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.exer.2025.110589,
title = {Teprotumumab reduces the proliferation and viability of pterygium fibroblasts.},
author = {Richard S and Obied B and Abu-Dbai J and Massalha J and Rabinovich Y and Vardizer Y and Zahavi A and Goldenberg-Cohen N.},
year = {2025},
journal = {Exp Eye Res},
doi = {10.1016/j.exer.2025.110589},
url = {https://doi.org/10.1016/j.exer.2025.110589}
}RIS
TY - JOUR TI - Teprotumumab reduces the proliferation and viability of pterygium fibroblasts. AU - Richard S AU - Obied B AU - Abu-Dbai J AU - Massalha J AU - Rabinovich Y AU - Vardizer Y AU - Zahavi A AU - Goldenberg-Cohen N. PY - 2025 JO - Exp Eye Res DO - 10.1016/j.exer.2025.110589 UR - https://doi.org/10.1016/j.exer.2025.110589 ER -
APA
S, R., B, O., J, A., J, M., Y, R., Y, V., A, Z., & N., G. (2025). Teprotumumab reduces the proliferation and viability of pterygium fibroblasts.. Exp Eye Res. https://doi.org/10.1016/j.exer.2025.110589
Source records
- europe-pmc · retrieved 2026-09-27T07:48:22.249Z